Cargando…

Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study

BACKGROUND AND PURPOSE: Clinical guidelines suggest that prophylactic antiepileptic drugs (AEDs) should be given to newly diagnosed seizure-naive brain tumor patients for up to 1 week after craniotomy. Yet, data suggest that prophylactic AEDs are used up to 12 months after surgery. A quality improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Dan Beverly, Kong, Xiao-Tang, Veenema, Tener Goodwin, Bota, Daniela A., Koirala, Binu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881735/
https://www.ncbi.nlm.nih.gov/pubmed/36727021
http://dx.doi.org/10.6004/jadpro.2022.13.8.4
_version_ 1784879173652709376
author Fu, Dan Beverly
Kong, Xiao-Tang
Veenema, Tener Goodwin
Bota, Daniela A.
Koirala, Binu
author_facet Fu, Dan Beverly
Kong, Xiao-Tang
Veenema, Tener Goodwin
Bota, Daniela A.
Koirala, Binu
author_sort Fu, Dan Beverly
collection PubMed
description BACKGROUND AND PURPOSE: Clinical guidelines suggest that prophylactic antiepileptic drugs (AEDs) should be given to newly diagnosed seizure-naive brain tumor patients for up to 1 week after craniotomy. Yet, data suggest that prophylactic AEDs are used up to 12 months after surgery. A quality improvement project was implemented to improve adherence to evidence-based prophylactic AED guidelines. METHODS: A quasi-experimental, pre- and post-test intervention design was used to assess the effect of a multiphase intervention on guideline adherence and prophylactic anticonvulsant prescription rates. The 16-week intervention consisted of provider education sessions, provider alerts, documentation templates, and a weekly audit and feedback. Participants included four providers and newly diagnosed seizure-naive brain tumor patients. Measures included guideline adherence rates and AED prescription rates extracted from chart review, and a provider attitude and knowledge survey. Analyses included descriptive statistics, Wilcoxon signed-rank tests, and Chi-square tests. RESULTS: Guideline adherence increased significantly (p < .01) from 4 months before implementation (15.8%) to 1 year before implementation (27.8%) and then to 93.3% after implementation. Provider knowledge showed clinically meaningful decreases in the likelihood to prescribe prophylactic AEDs (–.5 point) and increased understanding of prophylactic AED side effects (+0.5 point), although these were not statistically significant (p = .083). Finally, prophylactic AED prescription rates decreased by 2.2% (p = .119) compared with 4 months and 1 year before implementation (2.6%; p = .072). CONCLUSION: This project highlights the important role of provider education, provider alerts, a documentation template, and audit and feedback in improving guideline adherence rate. Findings suggest that the combination intervention and weekly audit and feedback strategy can improve guideline adherence to prophylactic anticonvulsant use in seizure-naive newly diagnosed brain tumor patients. IMPLICATIONS: By following prophylactic AED guideline recommendations, clinicians can avoid the potential side effects of anticonvulsant-induced cognitive, behavioral, and psychiatric issues that can impair patients' quality of life.
format Online
Article
Text
id pubmed-9881735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-98817352023-01-31 Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study Fu, Dan Beverly Kong, Xiao-Tang Veenema, Tener Goodwin Bota, Daniela A. Koirala, Binu J Adv Pract Oncol Research & Scholarship BACKGROUND AND PURPOSE: Clinical guidelines suggest that prophylactic antiepileptic drugs (AEDs) should be given to newly diagnosed seizure-naive brain tumor patients for up to 1 week after craniotomy. Yet, data suggest that prophylactic AEDs are used up to 12 months after surgery. A quality improvement project was implemented to improve adherence to evidence-based prophylactic AED guidelines. METHODS: A quasi-experimental, pre- and post-test intervention design was used to assess the effect of a multiphase intervention on guideline adherence and prophylactic anticonvulsant prescription rates. The 16-week intervention consisted of provider education sessions, provider alerts, documentation templates, and a weekly audit and feedback. Participants included four providers and newly diagnosed seizure-naive brain tumor patients. Measures included guideline adherence rates and AED prescription rates extracted from chart review, and a provider attitude and knowledge survey. Analyses included descriptive statistics, Wilcoxon signed-rank tests, and Chi-square tests. RESULTS: Guideline adherence increased significantly (p < .01) from 4 months before implementation (15.8%) to 1 year before implementation (27.8%) and then to 93.3% after implementation. Provider knowledge showed clinically meaningful decreases in the likelihood to prescribe prophylactic AEDs (–.5 point) and increased understanding of prophylactic AED side effects (+0.5 point), although these were not statistically significant (p = .083). Finally, prophylactic AED prescription rates decreased by 2.2% (p = .119) compared with 4 months and 1 year before implementation (2.6%; p = .072). CONCLUSION: This project highlights the important role of provider education, provider alerts, a documentation template, and audit and feedback in improving guideline adherence rate. Findings suggest that the combination intervention and weekly audit and feedback strategy can improve guideline adherence to prophylactic anticonvulsant use in seizure-naive newly diagnosed brain tumor patients. IMPLICATIONS: By following prophylactic AED guideline recommendations, clinicians can avoid the potential side effects of anticonvulsant-induced cognitive, behavioral, and psychiatric issues that can impair patients' quality of life. Harborside Press LLC 2022-11 2022-11-01 /pmc/articles/PMC9881735/ /pubmed/36727021 http://dx.doi.org/10.6004/jadpro.2022.13.8.4 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research & Scholarship
Fu, Dan Beverly
Kong, Xiao-Tang
Veenema, Tener Goodwin
Bota, Daniela A.
Koirala, Binu
Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
title Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
title_full Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
title_fullStr Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
title_full_unstemmed Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
title_short Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study
title_sort adherence to prophylactic anticonvulsant guidelines for newly diagnosed brain tumor patients: a quality improvement study
topic Research & Scholarship
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881735/
https://www.ncbi.nlm.nih.gov/pubmed/36727021
http://dx.doi.org/10.6004/jadpro.2022.13.8.4
work_keys_str_mv AT fudanbeverly adherencetoprophylacticanticonvulsantguidelinesfornewlydiagnosedbraintumorpatientsaqualityimprovementstudy
AT kongxiaotang adherencetoprophylacticanticonvulsantguidelinesfornewlydiagnosedbraintumorpatientsaqualityimprovementstudy
AT veenematenergoodwin adherencetoprophylacticanticonvulsantguidelinesfornewlydiagnosedbraintumorpatientsaqualityimprovementstudy
AT botadanielaa adherencetoprophylacticanticonvulsantguidelinesfornewlydiagnosedbraintumorpatientsaqualityimprovementstudy
AT koiralabinu adherencetoprophylacticanticonvulsantguidelinesfornewlydiagnosedbraintumorpatientsaqualityimprovementstudy